bisoprolol has been researched along with Blood Pressure, Low in 10 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the clinical effects and safety profile of initial monotherapy with either bisoprolol or enalapril in elderly patients with heart failure (HF)." | 9.13 | Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial. ( Dobre, D; Goulder, MA; Krum, H; van Veldhuisen, DJ; Willenheimer, R, 2008) |
| "The cardioselectivity and hypotensive properties of the beta 1-specific beta-blocker bisoprolol were investigated using a single-dose comparison of 10 and 20 mg bisoprolol, 100 mg atenolol, and placebo in 12 hypertensive asthmatic patients." | 9.06 | The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. ( Chatterjee, SS, 1986) |
| "Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 7.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
| "To assess the clinical effects and safety profile of initial monotherapy with either bisoprolol or enalapril in elderly patients with heart failure (HF)." | 5.13 | Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial. ( Dobre, D; Goulder, MA; Krum, H; van Veldhuisen, DJ; Willenheimer, R, 2008) |
| "The cardioselectivity and hypotensive properties of the beta 1-specific beta-blocker bisoprolol were investigated using a single-dose comparison of 10 and 20 mg bisoprolol, 100 mg atenolol, and placebo in 12 hypertensive asthmatic patients." | 5.06 | The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. ( Chatterjee, SS, 1986) |
| "Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 3.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
| "Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
| "Bisoprolol drug was administered at an initial dose of 1." | 1.40 | [Possible applications bisoprolol for heart rate control in young patients with connective tissue dysplasia]. ( Drokina, OV; Nechaeva, GI, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wongcharoen, W | 1 |
| Chotayaporn, T | 1 |
| Chutikhongchalermroj, K | 1 |
| Tantraworasin, A | 1 |
| Saeteng, S | 1 |
| Arworn, S | 1 |
| Rerkasem, K | 1 |
| Phrommintikul, A | 1 |
| Castaño-Amores, C | 1 |
| Antúnez-Rodríguez, A | 1 |
| Pozo-Agundo, A | 1 |
| García-Rodríguez, S | 1 |
| Martínez-González, LJ | 1 |
| Dávila-Fajardo, CL | 1 |
| Chen, YH | 1 |
| Lai, HC | 1 |
| Lee, WL | 1 |
| Liu, TJ | 1 |
| Taniguchi, T | 1 |
| Ohtani, T | 1 |
| Mizote, I | 1 |
| Kanzaki, M | 1 |
| Ichibori, Y | 1 |
| Minamiguchi, H | 1 |
| Asano, Y | 1 |
| Sakata, Y | 1 |
| Komuro, I | 1 |
| Thakrar, R | 1 |
| Shulman, R | 1 |
| Bellingan, G | 1 |
| Singer, M | 1 |
| Nechaeva, GI | 1 |
| Drokina, OV | 1 |
| Dobre, D | 1 |
| van Veldhuisen, DJ | 1 |
| Goulder, MA | 1 |
| Krum, H | 1 |
| Willenheimer, R | 1 |
| Ko, DT | 1 |
| Hebert, PR | 1 |
| Coffey, CS | 1 |
| Curtis, JP | 1 |
| Foody, JM | 1 |
| Sedrakyan, A | 1 |
| Krumholz, HM | 1 |
| Chatterjee, SS | 1 |
4 trials available for bisoprolol and Blood Pressure, Low
| Article | Year |
|---|---|
Effects of short-term bisoprolol on perioperative myocardial injury in patients undergoing non-cardiac surgery: a randomized control study.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Double-Blind Method; Heart Diseases; Humans; Hyp | 2021 |
Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
Topics: Aged; Antihypertensive Agents; Bisoprolol; Blood Pressure; Bradycardia; Chronic Disease; Cough; Drug | 2008 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
Topics: Adrenergic beta-Antagonists; Aged; Albuterol; Asthma; Bisoprolol; Blood Pressure; Bronchial Provocat | 1986 |
6 other studies available for bisoprolol and Blood Pressure, Low
| Article | Year |
|---|---|
Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Bisoprolol; Cytochrome P-450 CYP2D6; Genotype; | 2023 |
Iatrogenic Takotsubo Cardiomyopathy Following Overdose Norepinephrine Administration During Percutaneous Coronary Intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Bisoprolol; Coronar | 2020 |
Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dizziness; Dose-Response Rela | 2013 |
Management of a mixed overdose of calcium channel blockers, β-blockers and statins.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Bradycardia; Calcium Channel Blockers; Cardiac Pacin | 2014 |
[Possible applications bisoprolol for heart rate control in young patients with connective tissue dysplasia].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Blood Pressure; Bradycardia; Connective T | 2014 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; | 2000 |